Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2003 by Facet Biotech.
Recruitment status was  Active, not recruiting
Facet Biotech
Information provided by:
Facet Biotech Identifier:
First received: March 15, 2002
Last updated: June 23, 2005
Last verified: October 2003
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given